The Use of Digoxin in Patients With Worsening Chronic Heart Failure
Abstract
No abstract availableKeywords
Funding Information
- European Commission
- Amgen
- Novartis
- National Institutes of Health
- Health Resources and Services Administration
- Medtronic
This publication has 69 references indexed in Scilit:
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCEuropean Heart Journal, 2012
- The Romanian Acute Heart Failure Syndromes (RO-AHFS) RegistryAmerican Heart Journal, 2011
- Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trialThe Lancet, 2010
- Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled studyThe Lancet, 2010
- HFSA 2010 Comprehensive Heart Failure Practice GuidelineJournal of Cardiac Failure, 2010
- Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trialsEuropean Heart Journal, 2009
- Effects of Digoxin on Morbidity and Mortality in Diastolic Heart FailureCirculation, 2006
- Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)American Heart Journal, 2005
- The evolving pattern of digoxin intoxication: Observations at a large urban hospital from 1980 to 1988American Heart Journal, 1990
- Long-Term Digitalis Therapy Improves Left Ventricular Function in Heart FailureNew England Journal of Medicine, 1980